Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3. (Q44901078)
scientific article
Language:
(P31) (Q13442814)
(P304) 3645-3652
(P407) (Q1860)
(P433) 10
(P478) 64
(P577) Saturday, May 1, 2004
(P921) (Q29496)
(P1433) (Q326097)
(P1476) "Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3." (language: en)
(P2093) Prince George
Purva Bali
Pamela Cohen
Jianguo Tao
Fei Guo
Celia Sigua
Anasuya Vishvanath
Warren Fiskus
Anna Scuto
Srinivas Annavarapu
Lynn Moscinski
Kapil Bhalla
other details
description scientific article

External Links